Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds FingerMotion Q1 Sales $4.86M

FingerMotion Q1 Sales $4.86M

FingerMotion (NASDAQ:FNGR) reported $4.86 million in sales this quarter.

byBenzinga Newsdesk

July 18, 2022

1 minute read

FingerMotion (NASDAQ:FNGR) reported $4.86 million in sales this quarter.

Nasdaq, S&P 500 Futures Unfazed By Tesla Disappointment As Focus Shifts To Q4 GDP, Earnings: Analyst Sees Hope In This Bullish Indicator

By Shanthi Rexaline

January 25, 8:35 AM

Economists, on average, expect annualized quarter-over-quarter growth of 2%, slower than the third quarter's 4.9% growth.

AAL

UBS Maintains Neutral on Foot Locker, Lowers Price Target to $28

By Benzinga Newsdesk

July 15, 10:13 AM

UBS analyst Jay Sole maintains Foot Locker (NYSE:FL) with a Neutral and lowers the price target from $35 to $28.

News

HanesBrands And The Georgia Institute Of Technology Extend Long-Term Apparel Partnership

By Benzinga Newsdesk

January 10, 9:31 AM

HanesBrands extends exclusive rights partnership with Georgia Tech in the mass retail channel.HanesBrands (NYSE:HBI), the world's largest supplier of collegiate fan apparel, and the Georgia Institute of Technology

HBI

Corbus Pharmaceuticals Q1 FY23 R&D Expenses Grow 307% To $13.4M

By Vuk Zdinjak

May 9, 10:33 AM

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a precision oncology company, released financial results for the first quarter of 2023. Q1 2023 Financial Highlights

CRBP

FingerMotion Q1 Sales $4.86M

Related Posts

Nasdaq, S&P 500 Futures Unfazed By Tesla Disappointment As Focus Shifts To Q4 GDP, Earnings: Analyst Sees Hope In This Bullish Indicator

UBS Maintains Neutral on Foot Locker, Lowers Price Target to $28

HanesBrands And The Georgia Institute Of Technology Extend Long-Term Apparel Partnership

Corbus Pharmaceuticals Q1 FY23 R&D Expenses Grow 307% To $13.4M